PlainRecalls

Novel Laboratories, Inc.

Compiled from official public sources by the publisher.

3 recalls on record · Latest: Mar 21, 2018

Subscribe to new Novel Laboratories, Inc. recalls (RSS)

Agency notice ledger

Federal filing book Novel Laboratories, Inc. LIGHT-BOOK · SINGLE-AGENCY

#3,900 of 14,151 · 3 notices · 0.003% archive

  • BOOK 3 notices
  • RANK #3,900 of 14,151
  • SHARE 0.003% archive
  • AGENCY FDA Drug (3)
  • CAT drugs
  • CATS 1 category
  • LATEST Mar 21, 2018
  • PHOTO 3B Medical, Inc.

Nearest notice-volume peer: 3B Medical, Inc. (0 notice gap)

Novel Laboratories, Inc. accounts for about 0.003% of the 104,423-notice archive on 3 distinct filings — a light share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

Where Novel Laboratories, Inc. sits among 14,151 recalling firms

Novel Laboratories, Inc. ranks 3,900th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Novel Laboratories, Inc. vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

3 3900th of 14151 higher than 9,908 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-15

Novel Laboratories, Inc. in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Novel Laboratories, Inc. holds about 0.003% of archive notices alongside 3 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Low Mar 21, 2018

Lupin Hydrocodone Bitartrate and Homatropine Methylbromide Tablets, USP 5/1.5 mg Rx Only 30 Tablets Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873 Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202 NDC 43386-118-03 UPC 343386118038
FDA Drug Low Apr 19, 2017

Fluocinolone Acetonide Topical Solution USP 0.01% For Topical Use Only, Not for Ophthalmic Use, 60 mL bottle, Rx Only, Manufactured for Gavis Pharmaceuticals, LLC, Somerset NJ 08873, Manufactured by Novel Laboratories, Inc. Somerset, NJ 08873, NDC 43386-069-60
FDA Drug Low Sep 3, 2014

Famotidine for Oral Suspension, USP 40 mg/5 mL, Rx Only, Cherry-Banana-Mint Flavored, Not for Injection, Manufactured by: Novel Laboratories, Inc., Somerset, NJ 08873. Distributed by: Gavis Pharmaceuticals, LLC, Somerset, NJ 08873, NDC 43386-500-11.

Novel Laboratories, Inc. is a small archive contributor

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar recall count

Nearest multi-notice firms by distinct-event totals (3 here).

3B Medical, Inc. 3 7-Eleven, Inc. 3 A & C Best Food Trading 3 A B Nutrition, Inc. 3 A L I Technologies Ltd 3

Similar drugs volume

Nearest multi-notice firms in the same narrow category lane.

A B Nutrition, Inc. 3 Abrams Royal Pharmacy 3 Actavis 3 Ajanta Pharma Ltd. 3

Frequently Asked Questions

How many federal recall notices name Novel Laboratories, Inc.? ▼
PlainRecalls indexes 3 distinct federal recall events naming Novel Laboratories, Inc., aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Novel Laboratories, Inc. sit among other recalling firms? ▼
Novel Laboratories, Inc. ranks #3,900 of 14,151 by distinct recall-event count among 14,151 firms in this archive (70th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Novel Laboratories, Inc.'s notices? ▼
FDA Drug accounts for 3 of this firm's 3 indexed notices.
What product category dominates Novel Laboratories, Inc.'s filing book? ▼
Filings for Novel Laboratories, Inc. span 1 product category, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Novel Laboratories, Inc.: 3 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Novel Laboratories, Inc.; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026